Pay in 4 interest-free payments of $6.32 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
How it works: GHRH receptor agonism (CJC-1295): binds pituitary somatotrophs via the GHRH receptor, amplifying baseline GH pulse amplitude and duration over the course of days due to albumin binding Ghrelin receptor agonism (Ipamorelin): activates GHS-R1a with an earlier onset and more immediate GH secretion spike compared to GHRH analogs, providing a complementary time profile Sequential synergy: the two peptides act on distinct receptor systems and exhibit a combined GH output greater than either alone, with ipamorelin providing the acute peak and CJC-1295 sustaining elevated trough levels IGF-1 elevation: downstream GH signaling raises circulating IGF-1, the primary mediator of tissue repair, protein synthesis, and connective tissue remodeling
Explore the link between peptides and optimal health through the lens of a credible expert
It must not be administered to humans or animals outside of approved clinical trials
[5] Finally, combining this B-Complex Injection with other supplements containing the same vitamins (such as multivitamins or energy drinks) should be done carefully
The review documented GHK-Cus ability to promote balanced collagen synthesis, accelerate epithelialisation, and reduce fibrosis in both in vitro and pre-clinical models
Evidence type: Human RCT | Observational | Animal | In vitro | Regulatory Mechanism of Action AOD-9604 mimics the fat-metabolizing region of growth hormone
